Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Martin-Loeches

Showing results (101-110 of 465) with videos related to

Pageof 47
Sort By:
Intensive Care Medicine|November 14, 2018
Future of the ICU: finding treatable needles in the data haystackLieuwe D J Bos, Elie Azoulay, Ignacio Martin-Loeches
Current Opinion in Pulmonary Medicine|February 13, 2022
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patientsIgnacio Martin-Loeches, Saad Nseir, Alejandro Rodriguez, et al.
Intensive Care Medicine|January 9, 2020
Severe flu management: a point of viewAntoni Torres, Ignacio-Martin- Loeches, Wendy Sligl, et al.
Intensive Care Medicine|September 14, 2014
Impact of de-escalation on ICU patients' prognosisJan J De Waele, Matteo Bassetti, Ignacio Martin-Loeches
Intensive Care Medicine|November 2, 2014
Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: proJean-Marie Forel, Ignacio Martin-Loeches, Charles-Edouard Luyt
ERJ Open Research|July 27, 2022
Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative reviewSean Boyd, Saad Nseir, Alejandro Rodriguez, et al.
Current Opinion in Anaesthesiology|December 3, 2019
Antifungal use in the surgical ICU patientPedro Póvoa, Luís Coelho, David Nora, et al.
Seminars in Respiratory and Critical Care Medicine|January 18, 2022
HAP and VAP after GuidelinesPaul-Henri Wicky, Ignacio Martin-Loeches, Jean-François Timsit
Current Opinion in Infectious Diseases|February 22, 2022
Choosing antibiotic therapy for severe community-acquired pneumoniaIgnacio Martin-Loeches, Alexis Garduno, Pedro Povoa, et al.
Future Microbiology|January 22, 2024
Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidenceIgnacio Martin-Loeches, Christopher J Bruno, C Andrew DeRyke
Pageof 47

Showing results (101-110 of 465) with videos related to

Sort By:
Pageof 47
Intensive Care Medicine|November 14, 2018
Future of the ICU: finding treatable needles in the data haystackLieuwe D J Bos, Elie Azoulay, Ignacio Martin-Loeches
Current Opinion in Pulmonary Medicine|February 13, 2022
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patientsIgnacio Martin-Loeches, Saad Nseir, Alejandro Rodriguez, et al.
Intensive Care Medicine|January 9, 2020
Severe flu management: a point of viewAntoni Torres, Ignacio-Martin- Loeches, Wendy Sligl, et al.
Intensive Care Medicine|September 14, 2014
Impact of de-escalation on ICU patients' prognosisJan J De Waele, Matteo Bassetti, Ignacio Martin-Loeches
Intensive Care Medicine|November 2, 2014
Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: proJean-Marie Forel, Ignacio Martin-Loeches, Charles-Edouard Luyt
ERJ Open Research|July 27, 2022
Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative reviewSean Boyd, Saad Nseir, Alejandro Rodriguez, et al.
Current Opinion in Anaesthesiology|December 3, 2019
Antifungal use in the surgical ICU patientPedro Póvoa, Luís Coelho, David Nora, et al.
Seminars in Respiratory and Critical Care Medicine|January 18, 2022
HAP and VAP after GuidelinesPaul-Henri Wicky, Ignacio Martin-Loeches, Jean-François Timsit
Current Opinion in Infectious Diseases|February 22, 2022
Choosing antibiotic therapy for severe community-acquired pneumoniaIgnacio Martin-Loeches, Alexis Garduno, Pedro Povoa, et al.
Future Microbiology|January 22, 2024
Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidenceIgnacio Martin-Loeches, Christopher J Bruno, C Andrew DeRyke
Pageof 47